Quantitative diffusion imaging in breast cancer: A clinical prospective study
about
Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopyCorrelation of ADC value with pathologic indexes in colorectal tumor homografts in Balb/c mouse.High-resolution diffusion-weighted imaging for the separation of benign from malignant BI-RADS 4/5 lesions found on breast MRI at 3TDiagnostic assessment by dynamic contrast-enhanced and diffusion-weighted magnetic resonance in differentiation of breast lesions under different imaging protocolsMeta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions.Diffusion-weighted imaging: determination of the best pair of b-values to discriminate breast lesions.Correlation of diffusion-weighted imaging data with apoptotic and proliferation indexes in CT26 colorectal tumor homografts in balb/c mouse.Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.Breast MR with special focus on DW-MRI and DCE-MRIComparisons of multi b-value DWI signal analysis with pathological specimen of breast cancer.Apparent Diffusion Coefficient in Invasive Ductal Breast Carcinoma: Correlation with Detailed Histologic Features and the Enhancement Ratio on Dynamic Contrast-Enhanced MR Images.Conspicuity of breast lesions at different b values on diffusion-weighted imagingCharacterization of breast tumors using diffusion kurtosis imaging (DKI)Motion correction in diffusion-weighted MRI of the breast at 3T.Current Status and New Developments in Breast MRIDifferential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.Investigation of the optimal b-value to detect breast tumors with diffusion weighted imaging by 1.5-T MRI.Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurements.Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics.Assessment of tumor morphology on diffusion-weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWICan unenhanced breast MRI be used to decrease negative biopsy rates?MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft modelDiffusion-weighted imaging: Effects of intravascular contrast agents on apparent diffusion coefficient measures of breast malignancies at 3 Tesla.In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.Diagnostic performance of ADCs in different ROIs for breast lesions.Reproducibility of Apparent Diffusion Coefficient Measurements in Malignant Breast MassesMultiparametric MR Imaging of Breast Cancer.Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging.A Metric for Reducing False Positives in the Computer-Aided Detection of Breast Cancer from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Based Screening Examinations of High-Risk Women.18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted ImagingCorrelation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer.Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma.Potential of Diffusion-Weighted Imaging in the Characterization of Malignant, Benign, and Healthy Breast Tissues and Molecular Subtypes of Breast Cancer.Diffusion Weighted MR Imaging of Breast and Correlation of Prognostic Factors in Breast Cancer.The value of diffusion-weighted imaging in assessing the ADC changes of tissues adjacent to breast carcinomaDiffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications.Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibodySignificance of breast lesion descriptors in the ACR BI-RADS MRI lexicon.Case of the season: a giant fibroadenoma in the guise of a phyllodes tumor; characterization role of MRI.
P2860
Q30682911-A56EA140-C765-42DC-8FA5-23566BE3D5DAQ30852947-ECF5CEB0-9275-4FEE-A861-699E9BDC0134Q33584054-059F6051-0E06-43BE-A9DB-095CE198C875Q33677899-D10959F6-DF14-4E81-9A73-7425DC3A4B2DQ33781446-7C79CECB-F03F-41C7-B241-667C37B0EECDQ33823280-FE126707-954D-4D6C-AC2A-2D208778C69FQ33878704-9C7DD41D-C0AB-4533-BE72-9C124B6FFC40Q33964334-77534EDD-3A82-46D3-B031-6D2D06D635C5Q33965703-F4AB9EE0-A67C-4540-862D-E508FC8C7B16Q34097311-8DE6F802-D706-40C5-9475-58E34A00F0E1Q34127751-F041CD58-3D9F-4BEA-A7A2-3D511351535DQ34361556-FC76525B-247E-45A0-99CE-C9ED1DCE2BE9Q34536031-F5295FF0-DAA2-4104-AEE1-04502FD580DCQ34837660-E991E3CB-2DE1-453F-BA4F-6BC65363383DQ35016214-43F03FE5-2DE3-47A5-A70E-E77AA1945658Q35083961-4DA13455-8164-4144-8D38-04158CB6465AQ35093223-A565F814-1C7F-44B0-AC27-0975EF68F70BQ35420827-D2E788F4-B769-4A96-8FA1-005652416A48Q35447075-6D4B85FB-986B-4EB7-ACC2-0C409ECFC3B5Q35614931-DD01D401-181F-40EE-8C89-5A8266E6F482Q35838218-23930E6A-B84F-4FD7-88D6-2F8CCFCA163CQ35880395-2410F1F2-733D-45CF-853A-FDB24CC17F36Q35880477-627717AD-7C4C-4035-BE7A-A2367EFE5491Q35896750-EC3A16E5-EBC9-495C-807B-B3150910C2B8Q36182622-1E9537B7-6172-4915-9F41-A11513DC20CCQ36241769-B1F1A901-377E-4285-9502-2CA5ECA51472Q36353794-8F4BF426-6524-4B30-A5ED-78FB6BE28E4AQ36395910-FCEA7CF1-8F76-40BA-9F55-67C764A20632Q36417710-A747EE1B-4993-4E2C-9907-D6B9D417532CQ36488175-F318BF33-E6C5-48B1-87F4-0489E9F5C470Q36564214-CDFAA527-CB69-4A5F-9163-6A1802E3CF99Q36653229-9C59F9EF-896A-4271-B620-9CEC4C389CEBQ36672737-A59B862F-283A-4848-9FEF-D52D6FA05A14Q36925030-6E0E43DA-F1FB-40C9-AEF4-AC019FA2CF48Q36983710-B0200577-745B-4231-B708-B9D7CAE84A52Q37077683-AC534119-C42E-4D4D-81CB-2F96AA3BA572Q37087591-B53326FF-72EC-439B-883C-0B7535434C7CQ37133814-F8BADFAA-5A33-4A7C-A0C9-65F5690A1BE6Q37357319-B60F2180-7ED0-4AD2-8DEF-B1A4C95D51E8Q37473374-886E3F39-9CD7-473A-92FA-720F5F5ED579
P2860
Quantitative diffusion imaging in breast cancer: A clinical prospective study
description
scientific article published on 01 August 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2006
@uk
name
Quantitative diffusion imaging in breast cancer: A clinical prospective study
@en
Quantitative diffusion imaging in breast cancer: A clinical prospective study
@nl
type
label
Quantitative diffusion imaging in breast cancer: A clinical prospective study
@en
Quantitative diffusion imaging in breast cancer: A clinical prospective study
@nl
prefLabel
Quantitative diffusion imaging in breast cancer: A clinical prospective study
@en
Quantitative diffusion imaging in breast cancer: A clinical prospective study
@nl
P2093
P2860
P356
P1476
Quantitative diffusion imaging in breast cancer: a clinical prospective study
@en
P2093
Anne-Sophie Grell
Erika Rubesova
Marc Lemort
Shih-Li Chao
Viviane De Maertelaer
P2860
P304
P356
10.1002/JMRI.20643
P50
P577
2006-08-01T00:00:00Z